Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,010 | 15,212 | N/A | N/A | N/A |
| TOTAL | $8,107 | $15,299 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 54 | N/A | N/A | N/A | N/A |
| TOTAL | $54 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $8,161 | $15,299 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 979 | 371 | 1,438 | 0 | 0 |
| Accrued Expenses | 310 | 37 | N/A | N/A | N/A |
| TOTAL | $1,289 | $408 | $1,438 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,289 | $408 | $1,438 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 1 | N/A | N/A | N/A |
| Common Shares | 2 | 2 | 2 | N/A | N/A |
| Retained earnings | -18,283 | -9,029 | -1,440 | N/A | N/A |
| Other shareholders' equity | 18,524 | 19,944 | 0 | 0 | 0 |
| TOTAL | $6,872 | $14,890 | $-1,438 | $N/A | $N/A |
| Total Liabilities And Equity | $8,161 | $15,299 | $0 | $0 | $0 |